Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease (Q48172055)

9 February 2018

title

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease (English)

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

21 March 2024

0 references

0 references

5

Kaj Blennow

1 reference

9 February 2018

1

Maja Puchades

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559363

21 March 2024

author name string

Sara Folkesson Hansson

2

1 reference

9 February 2018

Niels Andreasen

4

1 reference

9 February 2018

Pia Davidsson

6

1 reference

9 February 2018

Carol L. Nilsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559363

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14559363

21 March 2024

publication date

1 October 2003

1 reference

9 February 2018

21 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14559363

full work available at URL

21 March 2024

https://api.elsevier.com/content/article/PII:S0169328X03003668?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

https://api.elsevier.com/content/article/PII:S0169328X03003668?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

21 March 2024

published in

Molecular Brain Research

1 reference

9 February 2018

volume

118

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

140-146

1 reference

9 February 2018

Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

21 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease

21 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Activation of complement and contact system in Alzheimer's disease.

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry

21 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

21 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia

21 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease

21 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Immunodetection of protein composition in cerebral amyloid extracts in Alzheimer's disease: enrichment of retinol-binding protein

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat.

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Quantitative evaluation of proteins in one- and two-dimensional polyacrylamide gels using a fluorescent stain

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrom

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Towards a high resolution separation of human cerebrospinal fluid.

21 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

Analysis of the human lumbar cerebrospinal fluid proteome

21 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.MOLBRAINRES.2003.08.005

21 March 2024

Identifiers

1 reference

9 February 2018

1 reference

9 February 2018